Press Releases - 2022-05-03

Date	Title	Company
03-May-2022	AmerisourceBergen & Biopharmaceutical Companies Discuss Strategies to Advance Pharmaceutical Innovation and Access at ThinkLive Commercialization Conference	Businesswire
03-May-2022	Global Lecithin & Phospholipids Markets Report 2022-2027: Growing Demand for Natural Food Additives and Increasing Consumer Awareness About Clean-Label Products Propelling the Market - ResearchAndMarkets.com	Businesswire
03-May-2022	Affini-T Therapeutics’ KRAS TCR T Cell Therapy Program to be Presented at the Annual Meeting of the American Society of Gene and Cell Therapy	Businesswire
03-May-2022	Stratpharma AG Appoints Michael Flowers President, North America Commercial Operations	Businesswire
03-May-2022	Robotics & AI Industry Leader Fady Saad and Automation & Sensor Industry Executive Mark Martin Launch First-of-its-Kind $50 Million Fund For Early-Stage Robotics, Automation, and AI Companies	Businesswire
03-May-2022	Worldwide Clinical Trials Names Rosemarie Corrigan Executive Vice President, Global Quality	Businesswire
03-May-2022	Sesen Bio Provides Strategic Update	Businesswire
03-May-2022	Tenaya Therapeutics to Present Preclinical Data on Gene Therapy Programs and Platform Capabilities at the American Society of Gene and Cell Therapy 25th Annual Meeting	Businesswire
03-May-2022	Seismic Therapeutic Appoints Maude Tessier, PhD, as Chief Business Officer	Businesswire
03-May-2022	Revolutionizing Quat Pesticide Determination and Quantitation Workflows to Protect Food Supply	Businesswire
03-May-2022	U.S. FDA Accepts Supplemental New Drug Application (sNDA) and Grants Priority Review for NUBEQA® (darolutamide) in Combination with Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)	Businesswire
03-May-2022	RG6501 (OpRegen®) Phase 1/2a Clinical Results Support the Potential for OpRegen to Slow, Stop or Reverse Disease Progression in Geographic Atrophy Secondary to Age-Related Macular Degeneration	Businesswire
03-May-2022	Revance to Release First Quarter Financial Results on Tuesday, May 10, 2022	Businesswire
03-May-2022	Danimer Scientific and Kemira Expand Exclusive Partnership to Commercialize Fully Biobased Barrier Coatings	Businesswire
03-May-2022	Massive Bio and Amber Specialty Pharmacy Announce Nationwide Partnership to Revolutionize Digitally Enabled Oncology Clinical Trial Recruitment through AI Technology Platform	Businesswire
03-May-2022	TecTraum Announces Completion of Multisite Clinical Trial Using pro2cool® Device for the Treatment of Concussions	Businesswire
03-May-2022	Exelixis’ Partner Ipsen Receives European Commission Approval for CABOMETYX® (cabozantinib) for Patients with Previously Treated Radioactive Iodine-Refractory Differentiated Thyroid Cancer	Businesswire
03-May-2022	NiKang Therapeutics and Hansoh Pharma Announce Strategic Collaboration and License Agreement for NKT2152 in Greater China	Businesswire
03-May-2022	Discovery Life Sciences™ Further Validates Quality of its Biospecimen Solutions by Participating in VERIF.i®, Scientist.com’s Supplier Pre-assessment Program	Businesswire
03-May-2022	Distributors Agree to Opioid Settlement With Washington State	Businesswire